R-Pharm in brief
R-Pharm is an unlisted company in the Healthcare sector, based in Moscow, Russia. It was founded in 2001. It employs about 3,600 people.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About R-Pharm
R-Pharm (Russian: Р-Фарм) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
R-Pharm timeline
- 2001
- 🏁Founded by Aleksey Repik
Events of R-Pharm from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
Not enough history yet.
Brands of R-Pharm (1)#
Pharmacy chain · since 2000
Source: Wikidata. Brands whose Wikidata item names R-Pharm (or a subsidiary of it) as owner, maker or parent organization; each brand's page links to its item
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| R-Pharm🇷🇺 | — | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Profile updated:
- Nov 5, 2026
Figures from Wikidata, Wikipedia, Wikimedia Commons, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at R-Pharm? Verify and update this profile — free
Show R-Pharm's ranking on your website Get the badge
The badge updates itself as the ranking changes.